T.C SB Goztepe Prof. Dr. Suleyman Yalcin City Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Chronic kidney disease1 trial
• Obesity1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Novo Nordisk A/S2 trials

Running trials

• Recruiting

  A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

  NCT06717698· Phase 2· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06065540· Phase 3· Novo Nordisk A/S· Source